(VIANEWS) – CleanSpark (CLSK), MACOM Technology Solutions Holdings (MTSI), Lifeway Foods (LWAY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CleanSpark (CLSK)
108% sales growth and 7.14% return on equity
CleanSpark, Inc. engages in bitcoin mining operations. It develops sustainable infrastructure for Bitcoin, a tool for financial independence and inclusion. The company was formerly known as Stratean Inc. and changed its name to CleanSpark, Inc. in November 2016. CleanSpark, Inc. was incorporated in 1987 and is headquartered in Henderson, Nevada.
Earnings Per Share
As for profitability, CleanSpark has a trailing twelve months EPS of $0.13.
PE Ratio
CleanSpark has a trailing twelve months price to earnings ratio of 119.85. Meaning, the purchaser of the share is investing $119.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.14%.
Yearly Top and Bottom Value
CleanSpark’s stock is valued at $15.58 at 16:22 EST, way below its 52-week high of $24.72 and way higher than its 52-week low of $3.38.
Previous days news about CleanSpark(CLSK)
- Cleanspark (clsk) dips more than broader market: what you should know. According to Zacks on Thursday, 20 June, "The upcoming earnings release of CleanSpark will be of great interest to investors. ", "Looking at valuation, CleanSpark is presently trading at a Forward P/E ratio of 37.46. "
2. MACOM Technology Solutions Holdings (MTSI)
32.1% sales growth and 6.58% return on equity
MACOM Technology Solutions Holdings, Inc., together with its subsidiaries, designs and manufactures analog semiconductor solutions for use in wireless and wireline applications across the radio frequency (RF), microwave, millimeter wave, and lightwave spectrum in the United States, China, the Asia Pacific, and internationally. The company offers a portfolio of standard and custom devices, including integrated circuits, multi-chip modules, diodes, amplifiers, switches and switch limiters, passive and active components, and subsystems. Its semiconductor products are electronic components that are incorporated in electronic systems, such as wireless basestations, high capacity optical networks, radar, and medical systems and test and measurement. The company serves various markets comprising telecommunication that includes carrier infrastructure, which comprise long-haul/metro, 5G, and fiber-to-the-X/passive optical network; data centres; and industrial and defense, including military and commercial radar, RF jammers, electronic countermeasures, and communication data links, as well as multi-market applications, such as industrial, medical, test and measurement, and scientific applications. It sells its products through direct sales force, applications engineering staff, independent sales representatives, resellers, and distributors. The company was founded in 1950 and is headquartered in Lowell, Massachusetts.
Earnings Per Share
As for profitability, MACOM Technology Solutions Holdings has a trailing twelve months EPS of $0.89.
PE Ratio
MACOM Technology Solutions Holdings has a trailing twelve months price to earnings ratio of 111.9. Meaning, the purchaser of the share is investing $111.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.58%.
Moving Average
MACOM Technology Solutions Holdings’s worth is below its 50-day moving average of $100.27 and way higher than its 200-day moving average of $87.92.
Sales Growth
MACOM Technology Solutions Holdings’s sales growth for the next quarter is 32.1%.
3. Lifeway Foods (LWAY)
14.9% sales growth and 23.09% return on equity
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream. It sells its products under the Lifeway, Glen Oaks Farms, and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was incorporated in 1986 and is based in Morton Grove, Illinois.
Earnings Per Share
As for profitability, Lifeway Foods has a trailing twelve months EPS of $0.85.
PE Ratio
Lifeway Foods has a trailing twelve months price to earnings ratio of 16.03. Meaning, the purchaser of the share is investing $16.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.09%.
Moving Average
Lifeway Foods’s value is way below its 50-day moving average of $20.07 and below its 200-day moving average of $14.15.
Volume
Today’s last reported volume for Lifeway Foods is 193325 which is 1.31% above its average volume of 190822.
Yearly Top and Bottom Value
Lifeway Foods’s stock is valued at $13.62 at 16:22 EST, way below its 52-week high of $28.61 and way above its 52-week low of $5.77.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 166.85M for the twelve trailing months.
4. Terreno Realty Corporation (TRNO)
13.5% sales growth and 5.43% return on equity
Terreno Realty Corporation (“Terreno”, and together with its subsidiaries, the “Company”) acquires, owns and operates industrial real estate in six major coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. All square feet, acres, occupancy and number of properties disclosed in these notes to the consolidated financial statements are unaudited. As of December 31, 2023, the Company owned 259 buildings aggregating approximately 16.0 million square feet, 45 improved land parcels consisting of approximately 152.4 acres, seven properties under development or redevelopment and approximately 62.7 acres of land entitled for future development. The Company is an internally managed Maryland corporation and elected to be taxed as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2010.
Earnings Per Share
As for profitability, Terreno Realty Corporation has a trailing twelve months EPS of $1.92.
PE Ratio
Terreno Realty Corporation has a trailing twelve months price to earnings ratio of 30.59. Meaning, the purchaser of the share is investing $30.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.43%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2024, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 3.07%.
Moving Average
Terreno Realty Corporation’s worth is above its 50-day moving average of $56.78 and under its 200-day moving average of $59.09.
Yearly Top and Bottom Value
Terreno Realty Corporation’s stock is valued at $58.73 at 16:22 EST, way under its 52-week high of $66.63 and way higher than its 52-week low of $50.42.
5. Atlanticus Holdings Corporation (ATLC)
11% sales growth and 19.62% return on equity
Atlanticus Holdings Corporation provides credit and related financial services and products to customers the United States. It operates in two segments, Credit as a Service, and Auto Finance. The Credit as a Service segment originates a range of consumer loan products, such as private label and general purpose credit cards originated by lenders through various channels, including retail and healthcare, direct mail solicitation, digital marketing, and partnerships with third parties; and offers credit to their customers for the purchase of various goods and services, including consumer electronics, furniture, elective medical procedures, healthcare, educational services, and home-improvements by partnering with retailers and service providers. In addition, it offers loan servicing, such as risk management and customer service outsourcing for third parties; and engages in testing and investment activities in consumer finance technology platforms. The Auto Finance segment purchases and/or services loans secured by automobiles from or for a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here, and used car business. This segment also provides floor plan financing and installment lending products. Further, the company invests in and services portfolios of credit card receivables. Atlanticus Holdings Corporation was founded in 1996 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Atlanticus Holdings Corporation has a trailing twelve months EPS of $4.25.
PE Ratio
Atlanticus Holdings Corporation has a trailing twelve months price to earnings ratio of 6.48. Meaning, the purchaser of the share is investing $6.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.62%.
6. Walker & Dunlop (WD)
10.5% sales growth and 5.01% return on equity
Walker & Dunlop, Inc., through its subsidiaries, originates, sells, and services a range of multifamily and other commercial real estate financing products and services for owners and developers of real estate in the United States. The company offers first mortgage, second trust, supplemental, construction, mezzanine, preferred equity, and small-balance loans. It also provides finance for multifamily, manufactured housing communities, student housing, affordable housing, and senior housing properties under the Fannie Mae's DUS program; and construction and permanent loans to developers and owners of multifamily housing, affordable housing, senior housing, and healthcare facilities. In addition, the company acts as a debt broker to work with life insurance companies, banks, and other institutional lenders to find debt and/or equity solution for the borrowers' needs; and offers property sales brokerage services to owners and developers of multifamily properties, and commercial real estate and multifamily property appraisals for various investors. Further, it provides appraisal and valuation services; and real estate-related investment banking and advisory services, including housing market research. Additionally, the company offers servicing and asset-managing the portfolio of loans; originates loans through its principal lending and investing activities; and manages third-party capital invested in tax credit equity funds focused on the affordable housing and other commercial real estate sectors. Walker & Dunlop, Inc. was founded in 1937 and is headquartered in Bethesda, Maryland.
Earnings Per Share
As for profitability, Walker & Dunlop has a trailing twelve months EPS of $2.74.
PE Ratio
Walker & Dunlop has a trailing twelve months price to earnings ratio of 34.96. Meaning, the purchaser of the share is investing $34.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.01%.
7. ICON plc (ICLR)
6.5% sales growth and 7.55% return on equity
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; and clinical research services, including biostatistics, clinical operations, clinical supplies management, covid-19, data management, decentralized & hybrid clinical solutions, endpoint adjudication services, interactive response technologies, investigator payments, medical affairs, medical writing and publishing, pharmacovigilance, and site and patient solutions. The company also provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. In addition, it offers commercial positioning, early phase, language, medical imaging, and strategic solutions, as well as clinical trial management, consulting, and contract staffing services. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, ICON plc has a trailing twelve months EPS of $8.24.
PE Ratio
ICON plc has a trailing twelve months price to earnings ratio of 39.26. Meaning, the purchaser of the share is investing $39.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.55%.
Sales Growth
ICON plc’s sales growth for the next quarter is 6.5%.
Yearly Top and Bottom Value
ICON plc’s stock is valued at $323.49 at 16:22 EST, under its 52-week high of $344.77 and way higher than its 52-week low of $219.00.
Moving Average
ICON plc’s worth is higher than its 50-day moving average of $313.64 and way above its 200-day moving average of $281.15.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.7%, now sitting on 8.23B for the twelve trailing months.
